Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression

Kidney International

Volumn 74, Issue 7, 2008, Pages 930-936

  Hedayati, S Susan ^a,b   Bosworth, Hayden B ^c,d   Briley, Libbie P ^e   Sloane, Richard J ^c   Pieper, Carl F ^c   Kimmel, Paul L ^f   Szczech, Lynda A ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d DURHAM VA MEDICAL CENTER   (United States)

^e IQVIA   (United States)

^f GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Depression; Dialysis; Hospitalization; Mortality

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; FEMALE; HAZARD RATIO; HEMODIALYSIS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PHYSICIAN; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE DIFFERENCE; SEX DIFFERENCE; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SURVIVAL RATE;

ADULT; AGED; DEATH; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INTERVIEWS AS TOPIC; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHYSICIANS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; SURVIVAL ANALYSIS;

EID: 51849083329     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.311     Document Type: Article

References (80)

1. Cukor D, Peterson RA, Cohen SD et al. Depression in end-stage renal disease hemodialysis patients. Nat Clin Pract Nephrol 2006; 2: 678-687.
2. Lopes AA, Bragg J, Young E et al. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int 2002; 62: 199-207.
3. Boulware LE, Liu Y, Fink NE et al. Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality. Clin J Am Soc Nephrol 2006; 1: 496-504.
4. Kimmel PL, Peterson RA, Weihs KL et al. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int 2000; 57: 2093-2098.
5. Hedayati SS, Bosworth HB, Kuchibhatla M et al. The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int 2006; 69: 1662-1668.
6. Snow V, Lascher S, Mottur-Pilson C. Pharmacologic treatment of acute major depression and dysthymia. Ann Intern Med 2000; 132: 738-742.
7. Kimmel PL, Weihs K, Peterson RA. Survival in hemodialysis patients: the role of depression. J Am Soc Nephrol 1993; 4: 12-27.
8. Hedayati SS, Jiang W, O'Connor CM et al. The association between depression and chronic kidney disease and mortality among patients hospitalized with congestive heart failure. Am J Kidney Dis 2004; 44: 207-215.
9. Peterson RA, Kimmel PL, Sacks CR et al. Depression, perception of illness and mortality in patients with end-stage renal disease. Int J Psychiatry Med 1991; 21: 343-354.
10. Kimmel PL, Peterson RA. Depression in end-stage renal disease patients treated with hemodialysis: tools, correlates, outcomes, and needs. Semin Dial 2005; 18: 91-97.
11. Hedayati SS, Grambow SC, Szczech LA et al. Physician-diagnosed depression as a correlate of hospitalizations in patients receiving long-term hemodialysis. Am J Kidney Dis 2005; 46: 642-649.
12. US Renal Data System. USRDS 2006 Annual Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, 2006.
13. McMurray JJ, Velazquez EJ, Solomon SD et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295.
14. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
15. Rosengren A, Hawken S, Ounpuu S et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11,119 cases and 13,648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 953-962.
16. Wassertheil-Smoller S, Shumaker S, Ockene J et al. Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI). Arch Intern Med 2004; 164: 289-298.
17. Anda R, Williamson D, Jones D et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology 1993; 4: 285-294.
18. Pratt LA, Ford DE, Crum RM et al. Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation 1996; 94: 3123-3129.
19. Ariyo AA, Haan M, Tangen CM et al. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. Circulation 2000; 102: 1773-1779.
20. Wassertheil-Smoller S, Applegate WB, Berge K et al. Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systoloc Hypertension in the elderly). Arch Intern Med 1996; 156: 553-561.
21. Penninx BW, Guralnik JM, Mendes de Leon CF et al. Cardiovascular events and mortality in newly and chronically depressed persons 70 years of age. Am J Cardiol 1998; 81: 988-994.
22. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction impact on 6-month survival. JAMA 1993; 270: 1819-1825.
23. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91: 999-1005.
24. Bush DE, Ziegelstein RC, Tayback M et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 2001; 88: 337-341.
25. Lesperance F, Frasure-Smith N, Talajic M et al. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002; 105: 1049-1053.
26. Frasure-Smith N, Lesperance F, Gravel G et al. Social support, depression, and mortality during the first year after myocardial infarction. Circulation 2000; 101: 1919-1924.
27. Carinci F, Nicolucci A, Ciampi A et al. Role of interactions between psychological and clinical factors in determining 6-month mortality among patients with acute myocardial infarction: application of recursive partitioning techniques to the GISSI-2 database. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico. Eur Heart J 1997; 18: 835-845.
28. Ziegelstein RC. Depression in patients recovering from a myocardial infarction. JAMA 2001; 286: 1621-1627.
29. Walters BA, Hays RD, Spritzer KL et al. Health-related quality of life, depressive symptoms, anemia, and malnutrition at dialysis initiation. Am J Kidney Dis 2002; 40: 1185-1194.
30. Einwohner R, Bernardini J, Fried L et al. The effect of depressive symptoms on survival in peritoneal dialysis patients. Perit Dial Int 2004; 24: 256-263.
31. Lopes AA, Albert JM, Young EW et al. Screening for depression in hemodialysis patients: associations with diagnosis, treatment, and outcomes in the DOPPS. Kidney Int 2004; 66: 2047-2053.
32. Andreucci VE, Fissell RB, Bragg-Gresham JL et al. Dialysis outcomes and practice patterns study (DOPPS) data on medications in hemodialysis patients. Am J Kidney Dis 2004; 44(S2): S61-S67.
33. Zimmermann PR, Camey SA, Mari Jde J. A cohort study to assess the impact of depression on patients with kidney disease. Int J Psychiatry Med 2006; 36: 457-468.
34. Troidle L, Watnick S, Wuerth DB et al. Depression and its association with peritonitis in long-term peritoneal dialysis patients. Am J Kidney Dis 2003; 42: 350-354.
35. Soucie JM, McClellan WM. Early death in dialysis patients: risk factors and impact on incidence and mortality rates. J Am Soc Nephrol 1996; 10: 2169-2175.
36. Shulman R, Price JDE, Spinelli J. Biopsychosocial aspects of long-term survival on end-stage renal failure therapy. Psychol Med 1989; 19: 945-954.
37. Wai L, Burton H, Richmond J et al. Influence of psychosocial factors on survival of home dialysis patients. Lancet 1981; 2: 1155-1156.
38. Burton HJ, Kline SA, Lindsay RM et al. The relationship of depression to survival in chronic renal failure. Psychosom Med 1986; 48: 261-269.
39. Ziarnik JP, Freeman CW, Sherrard DJ et al. Psychological correlates of survival on renal dialysis. J Nerv Ment Dis 1977; 164: 210-213.
40. Devins GM, Mann J, Mandin H. Psychosocial predictors of survival in end-stage renal disease. J Nerv Ment Dis 1990; 178: 127-133.
41. Christensen AJ, Wiebe JS, Smith TW et al. Predictors of survival among hemodialysis patients: effects of perceived family support. Health Psychol 1994; 13: 521-525.
42. Drayer RA, Piraino B, Reynolds III CF et al. Characteristics of depression in hemodialysis patients: symptoms, quality of life, and mortality risk. Gen Hosp Psychiatry 2006; 28: 306-312.
43. Kimmel PL, Peterson RA. Depression in patients with end-stage renal disease treated with dialysis: has the time to treat arrived? Clin J Am Soc Nephrol 2006; 1: 349-352.
44. Cohen SD, Norris L, Acquaviva K et al. Screening, diagnosis, and treatment of depression in patients with end-stage renal disease. Clin J Am Soc Nephrol 2007; 2: 1332-1342.
45. Cukor D, Cohen SD, Peterson RA et al. Psychosocial aspects of chronic disease: ESRD as a paradigmatic illness. J Am Soc Nephrol 2007; 18: 3042-3055.
46. Cukor D, Coplan J, Brown C et al. Depression and anxiety in urban hemodialysis patients. Clin J Am Soc Nephrol 2007; 2: 484-490.
47. Whooley MA. Depression and cardiovascular disease: healing the broken-hearted. JAMA 2006; 295: 2874-2881.
48. McCaffery JM, Frasure-Smith N, Dube MP. Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosom Med 2006; 68: 187-200.
49. Scherrer JF, Hong X, Bucholz KK et al. A twin study of depression symptoms, hypertension, and heart disease in middle-aged men. Psychosom Med 2003; 65: 548-557.
50. Ziegelstein RC, Fauerbach JA, Stevens SS et al. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 2000; 160: 1818-1823.
51. Barefoot JC, Burg MM, Carney RM. Aspects of social support associated with depression at hospitalization and follow-up assessment among cardiac patients. J Cardiopulm Rehabil 2003; 23: 404-412.
52. Bonnet F, Irving K, Terra JL et al. Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis 2005; 178: 339-344.
53. Friend R, Hatchett L, Wadhwa NK et al. Serum albumin and depression in end-stage renal disease. Adv Perit Dial 1997; 13: 155-157.
54. Koo JR, Yoon JW, Kim SG et al. Association of depression with malnutrition in chronic hemodialysis patients. Am J Kidney Dis 2003; 41: 1037-1042.
55. Carney RM, Blumenthal JA, Stein PK. Depression, heart rate variability, and acute myocardial infarction. Circulation 2001; 104: 2024-2028.
56. Kleiger RE, Miller JP, Bigger JT et al. Depressed heart rate variability and its association with mortality after myocardial infarction. Am J Cardiol 1987; 59: 256-262.
57. Krittayaphong R, Cascio WE, Light KC. Heart rate variability in patients with coronary artery disease: differences in patients with higher and lower depression scores. Psychosom Med 1997; 59: 231-235.
58. Otte C, Marmar CR, Pipkin SS et al. Depression and 24-h urinary cortisol in medical outpatients with coronary heart disease: the Heart and Soul Study. Biol Psychiatry 2004; 56: 241-247.
59. Otte C, Neylan TC, Pipkin S et al. Depressive symptoms and 24-h urinary norepinephrine excretion levels in patients with coronary disease: findings from the Heart and Soul Study. Am J Psychiatry 2005; 162: 2139-2145.
60. Empana JP, Sykes DH, Luc G. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2005; 111: 2299-2305.
61. Butler J, Leonard BE. The platelet serotonergic system in depression and following sertraline treatment. Int Clin Psychopharmacol 1988; 3: 343-347.
62. Serebruany VL, Glassman AH, Malinin AI et al. (SADHART Study Group). Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events. Circulation 2003; 108: 939-944.
63. Serebruany VL, Glassman AH, Malinin AI et al. Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials. Blood Coagul Fibrinolysis 2003; 14: 563-567.
64. Serebruany VL, Suckow RF, Cooper TB et al. Sertraline antidepressant heart attack randomized trial. Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. Am J Psychiatry 2005; 162: 1165-1170.
65. Blazer DG, Hybels CF, Simonsick EM et al. Marked differences in antidepressant use by race in an elderly community sample: 1986-1996. Am J Psychiatry 2000; 157: 1089-1094.
66. Kimmel PL, Patel SS, Peterson RA. Depression in African American patients with kidney disease. J Natl Med Assoc 2002; 94(8 Suppl): 92S-103S.
67. Glassman AH, O'Connor CM, Califf RM et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288: 701-709.
68. Blumenfield M, Levy NB, Spinowitz B et al. Fluoxetine in depressed patients on dialysis. Int J Psychiatry Med 1997; 27: 71-80.
69. Wuerth D, Finkelstein SH, Kliger AS et al. Chronic peritoneal dialysis patients diagnosed with clinical depression: results of pharmacologic therapy. Semin Dial 2003; 16: 424-427.
70. Wuerth D, Finkelstein SH, Finkelstein FO. The identification and treatment of depression in patients maintained on dialysis. Semin Dial 2005; 18: 142-146.
71. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975; 23: 433-441.
72. Beck AT, Ward CH, Mendelson M et al. An inventory for measuring depression. Arch Gen Psych 1961; 4: 561-571.
73. Craven JL, Rodin GM, Littlefield C. The BDI as a screening device for major depression in renal dialysis patients. Int J Psychiatry Med 1998; 18: 365-374.
74. Radloff L. The CES-D Scale: a self-report depression scale for research in the general population. App Psychol Meas 1977; 1: 385-401.
75. Skre I, Onstad S, Torgensen S et al. High interrater reliability for the Structured Clinical Interview for DSM-III-R axis I (SCID I). Acta Psychiatr Scand 1991; 84: 167-173.
76. Williams JBW, Gibbon M, First MB et al. The structured clinical interview for DSM-III-R (SCID) II: multi-site test-retest reliability. Arch Gen Psychiatry 1992; 49: 630-636.
77. Booth BM, Kirchner JE, Hamilton G et al. Diagnosing depression in the medically ill: validity of a lay-administered structured diagnostic interview. J Psychiatr Rese 1998; 32: 353-360.
78. Kimmel PL, Varela MP, Peterson RA et al. Interdialytic weight gain and survival in hemodialysis patients: effects of duration of ESRD and diabetes mellitus. Kidney Int 2000; 57: 1141-1151.
79. t/V: an analysis of error. J Am Soc Nephrol 1993; 4: 1205-1213.
80. Clase CM, St Pierre MW, Churchill DN. Conversion between bromcresol green- and bromcresol purple-measured albumin in renal disease. Nephrol Dial Transplant 2001; 16: 1925-1929.